Atomo Diagnostics (ASX:AT1) EBIT per Share: A$-0.01 (TTM As of Dec. 2025)


What is Atomo Diagnostics EBIT per Share?

Atomo Diagnostics ASX:AT1 EBIT per Share is A$-0.01 as of Dec. 2025. The stock has 4 warning signs investors should review. Among 690 Medical Devices & Instruments companies, Atomo Diagnostics ranks better than 50.72% on this metric.

Atomo Diagnostics's EBIT per Share for the six months ended in Dec. 2025 was A$-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 9.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Atomo Diagnostics's EBIT per Share or its related term are showing as below:

ASX:AT1' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 1.6   Med: 2.9   Max: 9.8
Current: 9.8

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Atomo Diagnostics was 9.80% per year. The lowest was 1.60% per year. And the median was 2.90% per year.

ASX:AT1's 3-Year EBIT Growth Rate is ranked better than
50.72% of 690 companies
in the Medical Devices & Instruments industry
Industry Median: 9.5 vs ASX:AT1: 9.80

Atomo Diagnostics's EBIT for the six months ended in Dec. 2025 was A$-2.91 Mil.

Atomo Diagnostics  (ASX:AT1) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Atomo Diagnostics EBIT per Share Related Terms

Atomo Diagnostics EBIT per Share Historical Data

* Premium members only.

The historical data trend for Atomo Diagnostics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atomo Diagnostics EBIT per Share Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT per Share
Get a 7-Day Free Trial -0.01 -0.01 -0.02 -0.01 -0.01

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.00 -0.00 -0.00

Atomo Diagnostics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Atomo Diagnostics's EBIT per Share for the fiscal year that ended in Jun. 2025 is calculated as

EBIT per Share(A: Jun. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-4.965/647.095
=-0.01

Atomo Diagnostics's EBIT per Share for the quarter that ended in Dec. 2025 is calculated as

EBIT per Share(Q: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.908/802.514
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of A$-0.01 mean?
Atomo Diagnostics (ASX:AT1) has a EBIT per Share of A$-0.01 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Atomo Diagnostics and its competitors. According to the industry distribution chart, Atomo Diagnostics ranks #340 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 49.3%.
Is Atomo Diagnostics' EBIT per Share too high?
Atomo Diagnostics' current EBIT per Share is A$-0.01. Based on the distribution chart, Atomo Diagnostics ranks #340 out of 690 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Atomo Diagnostics' EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Atomo Diagnostics ranks #340 out of 690 companies for EBIT per Share. This puts Atomo Diagnostics in the upper half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Atomo Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atomo Diagnostics's current EBIT per Share is A$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 10% below its estimated fair value. The current EBIT per Share is A$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current EBIT per Share is A$-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atomo Diagnostics Business Description

Address 3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.